Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

James E Wagner Cultivation Corp JWCAF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
James E. Wagner Cultivation Corp, through its subsidiary is a licensed producer of medical cannabis focusing on producing clean, consistent cannabis using an advanced and proprietary aeroponic platform named GrowthSTORM. The company's operations are based in Kitchener, Ontario.


GREY:JWCAF - Post by User

James E Wagner Cultivation Corp
Bullboard Posts
User Avatar Image
(3)
•••
Comment by CDOKingon Jul 17, 2018 9:11am
47 Views
Post# 28325761

RE:Might be a good idea to do a press release NOW!

RE:Might be a good idea to do a press release NOW!
Aww is the volalitity scaring you? Jr companies get blown out all of the time and often it has nothing to do with the fundementals of their business. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities